The Establishment of a Contract Research Laboratory
Biotest Facility is a Danish contract research organization (CRO) focused on accelerating biotech and pharmaceutical innovation. By integrating state‑of‑the‑art in vivo models with comprehensive analytics and data science, we transform ideas into validated data – fast, transparently, and with meticulous scientific rigor. We operate as a data‑driven partner, guiding projects from concept to decision‑ready outcomes.
We guide you throughout your research, from idea to data delivery. Our solutions are made specifically to meet the demands of your research.
Core Capabilities
In Vivo Models
Robust rodent models for pharmacology, efficacy, and safety studies.
Study design, execution, and regulatory-ready documentation.
Scalable capacity with a focus on quality, reproducibility, and data traceability.
Analytical Services and Omics
Proteomics – including targeted panels and discovery approaches for assessing biomarkers.
Transcriptomics and gene expression profiling – including qPCR, NanoString, dPCR, RNA-Seq prep and sequencing.
Small-molecule detection and quantification – including our LC-MS/MS workflows.
Genotyping and targeted SNP panels.
Biomarker Discovery and Validation
Biomarker signature discovery in clinical and preclinical settings.
Biomarker panels aligned with patient cohorts and hospital collaborations.
Bioinformatics and Biostatistics
Data management and integration across platforms.
Customized statistical analysis and result interpretation.
Visualization, reporting, and decision-support for researchers and sponsors.
Laboratory Excellence and Compliance
Modern, validated laboratory infrastructure for high-quality data generation.
Why Biotest Facility
End‑to‑end project support: from concept to data‑driven decision‑making.
Integrated capabilities: seamless collaboration across in vivo, molecular analytics, and bioinformatics.
International potential: scalable services designed to support global biotech and pharma partners.
Flexible collaboration: open, partner‑driven approach to meet diverse project needs.
After integrating BioXpedia assets in 2025, Biotest Facility emerges as a unified, performance‑driven CRO with a renewed culture of data excellence. We are investing in upgraded in vivo facilities, expanded analytical capacities, and an invigorated global outreach to bring innovative therapies to patients faster. Our roadmap includes strengthening lab infrastructure, expanding biomarker programs, and forging strategic collaborations with biotech, pharma, research hospitals and university partners.
Partnerships and contact
We welcome collaboration with biotech startups, mid‑cap biotech companies, and pharmaceutical sponsors seeking comprehensive, data‑driven CRO services. Reach out to discuss how Biotest Facility can support your research program or project milestones.
Contact us
Let’s turn your ideas into validated data. Contact us to explore how Biotest Facility can accelerate your next project.